Clinical and immunological recovery of children with acute lymphocytic leukemia admitted to "total therapy" studies.
D000917:Antibody Formation; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D008214:Lymphocytes / Q000276:immunology; D008581:Meningitis / Q000517:prevention & control; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D011241:Prednisone / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D012075:Remission, Spontaneous; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate